Chemistry:Famprofazone
From HandWiki
Short description: NSAID analgesic medication
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C24H31N3O |
| Molar mass | 377.532 g·mol−1 |
| 3D model (JSmol) | |
| |
Famprofazone (Gewodin, Gewolen) is a nonsteroidal anti-inflammatory agent (NSAID) of the pyrazolone series which is available over-the-counter in some countries such as Taiwan.[1][2][3] It has analgesic, anti-inflammatory, and antipyretic effects.[1][2] Famprofazone has been known to produce methamphetamine as an active metabolite, with 15–20% of an oral dose being converted to it.[4][5] As a result, famprofazone has occasionally been implicated in causing positives on drug tests for amphetamines.[3]
See also
References
- ↑ 1.0 1.1 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. pp. 1932. ISBN 3-88763-075-0. https://books.google.com/books?id=5GpcTQD_L2oC&q=famprofazone&pg=PA426.
- ↑ 2.0 2.1 Concise dictionary of pharmacological agents: properties and synonyms. Kluwer Academic. 1999. pp. 342. ISBN 0-7514-0499-3. https://books.google.com/books?id=mqaOMOtk61IC&q=famprofazone&pg=PA118.
- ↑ 3.0 3.1 "Famprofazone use can be misinterpreted as methamphetamine abuse". Journal of Analytical Toxicology 34 (6): 347–353. 2010. doi:10.1093/jat/34.6.347. PMID 20663288.
- ↑ "Plasma and urinary concentrations of methamphetamine after oral administration of famprofazone to man". Xenobiotica; the Fate of Foreign Compounds in Biological Systems 22 (3): 377–384. March 1992. doi:10.3109/00498259209046649. PMID 1496827.
- ↑ "Identification of new urinary metabolites of famprofazone in humans". Journal of Analytical Toxicology 22 (1): 55–60. 1998. doi:10.1093/jat/22.1.55. PMID 9491970.
| Pyrazolones / Pyrazolidines | |
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances | |
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) | |
| Coxibs | |
| Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. | |
| DRAs |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRAs |
| ||||||||||||||
| SRAs |
| ||||||||||||||
| Others |
| ||||||||||||||
| CAR |
|
|---|---|
| PXR |
|
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
0.00 ![]() ![]() ![]() ![]() (0 votes) |

